144 0001783165 XXXXXXXX LIVE 0001880438 AN2 Therapeutics, Inc. 001-41331 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090 Adjuvant Global Health Technology Fund, L.P. Shareholder Common Merrill

555 California Street Floor 18 San Francisco CA 94104

84093 1755861.84 29741445 01/16/2024 NASDAQ Common 11/20/2019 Investment fund shares Issuer N 84093 11/20/2019 Cash N Adjuvant Global Health Technology Fund, L.P.

C/O Adjuvant Capital, LP 501 Fifth Avenue, Suite 1404 New York NY 10017

Common 11/14/2023 1522 24574.21 Adjuvant Global Health Technology Fund DE, L.P.

C/O Adjuvant Capital, LP 501 Fifth Avenue, Suite 1404 New York NY 10017

Common 11/14/2023 288 4650.04 01/16/2024 Kabeer Aziz